Knockdown of RFC4 inhibits cell proliferation of oral squamous cell carcinoma in vitro and in vivo

Oral squamous cell carcinoma (OSCC) is the one of the most common types of malignant tumor found in the head and neck area. Replication factor C subunit 4 (RFC4), an oncogene active in various human cancers, has been rarely studied in OSCC. In the present study, bioinformatics analysis identified RF...

Full description

Saved in:
Bibliographic Details
Main Authors: Pengyue You, Di Wang, Zheng Liu, Shuzhen Guan, Ning Xiao, Haotian Chen, Xin Zhang, Lichuan Wu, Guizhen Wang, Haitao Dong
Format: Article
Language:English
Published: Wiley 2025-02-01
Series:FEBS Open Bio
Subjects:
Online Access:https://doi.org/10.1002/2211-5463.13929
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832544079794143232
author Pengyue You
Di Wang
Zheng Liu
Shuzhen Guan
Ning Xiao
Haotian Chen
Xin Zhang
Lichuan Wu
Guizhen Wang
Haitao Dong
author_facet Pengyue You
Di Wang
Zheng Liu
Shuzhen Guan
Ning Xiao
Haotian Chen
Xin Zhang
Lichuan Wu
Guizhen Wang
Haitao Dong
author_sort Pengyue You
collection DOAJ
description Oral squamous cell carcinoma (OSCC) is the one of the most common types of malignant tumor found in the head and neck area. Replication factor C subunit 4 (RFC4), an oncogene active in various human cancers, has been rarely studied in OSCC. In the present study, bioinformatics analysis identified RFC4 as a potential key target in OSCC progression. Additional experiments showed that RFC4 expression was significantly higher in OSCC tumor tissues than in normal tissues. Knockdown of RFC4 led to G2/M phase cell cycle arrest and inhibited the proliferation of OSCC cells both in vitro and in vivo. High RFC4 expression in OSCC tumors was linked to increased levels of MET, along with reduced levels of CD274 and CD160. Overall, the present study reveals that RFC4 may play a pivotal role in OSCC tumorigenesis and could serve as a potential predictive marker for the efficacy of immunotherapy.
format Article
id doaj-art-b45470d90b4f456ab476ede0835bf7c3
institution Kabale University
issn 2211-5463
language English
publishDate 2025-02-01
publisher Wiley
record_format Article
series FEBS Open Bio
spelling doaj-art-b45470d90b4f456ab476ede0835bf7c32025-02-03T10:59:31ZengWileyFEBS Open Bio2211-54632025-02-0115234635810.1002/2211-5463.13929Knockdown of RFC4 inhibits cell proliferation of oral squamous cell carcinoma in vitro and in vivoPengyue You0Di Wang1Zheng Liu2Shuzhen Guan3Ning Xiao4Haotian Chen5Xin Zhang6Lichuan Wu7Guizhen Wang8Haitao Dong9Department of Stomatology, Peking Union Medical College Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing ChinaDepartment of Clinical Laboratory, Peking Union Medical College Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing ChinaState Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing ChinaMedical College of Guangxi University Nanning ChinaDepartment of Stomatology, Peking Union Medical College Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing ChinaDepartment of Stomatology, Peking Union Medical College Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing ChinaDepartment of Stomatology, Peking Union Medical College Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing ChinaMedical College of Guangxi University Nanning ChinaState Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing ChinaDepartment of Stomatology, Peking Union Medical College Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing ChinaOral squamous cell carcinoma (OSCC) is the one of the most common types of malignant tumor found in the head and neck area. Replication factor C subunit 4 (RFC4), an oncogene active in various human cancers, has been rarely studied in OSCC. In the present study, bioinformatics analysis identified RFC4 as a potential key target in OSCC progression. Additional experiments showed that RFC4 expression was significantly higher in OSCC tumor tissues than in normal tissues. Knockdown of RFC4 led to G2/M phase cell cycle arrest and inhibited the proliferation of OSCC cells both in vitro and in vivo. High RFC4 expression in OSCC tumors was linked to increased levels of MET, along with reduced levels of CD274 and CD160. Overall, the present study reveals that RFC4 may play a pivotal role in OSCC tumorigenesis and could serve as a potential predictive marker for the efficacy of immunotherapy.https://doi.org/10.1002/2211-5463.13929immunotherapyoral squamous cell carcinomaproliferationRFC4WGCNA
spellingShingle Pengyue You
Di Wang
Zheng Liu
Shuzhen Guan
Ning Xiao
Haotian Chen
Xin Zhang
Lichuan Wu
Guizhen Wang
Haitao Dong
Knockdown of RFC4 inhibits cell proliferation of oral squamous cell carcinoma in vitro and in vivo
FEBS Open Bio
immunotherapy
oral squamous cell carcinoma
proliferation
RFC4
WGCNA
title Knockdown of RFC4 inhibits cell proliferation of oral squamous cell carcinoma in vitro and in vivo
title_full Knockdown of RFC4 inhibits cell proliferation of oral squamous cell carcinoma in vitro and in vivo
title_fullStr Knockdown of RFC4 inhibits cell proliferation of oral squamous cell carcinoma in vitro and in vivo
title_full_unstemmed Knockdown of RFC4 inhibits cell proliferation of oral squamous cell carcinoma in vitro and in vivo
title_short Knockdown of RFC4 inhibits cell proliferation of oral squamous cell carcinoma in vitro and in vivo
title_sort knockdown of rfc4 inhibits cell proliferation of oral squamous cell carcinoma in vitro and in vivo
topic immunotherapy
oral squamous cell carcinoma
proliferation
RFC4
WGCNA
url https://doi.org/10.1002/2211-5463.13929
work_keys_str_mv AT pengyueyou knockdownofrfc4inhibitscellproliferationoforalsquamouscellcarcinomainvitroandinvivo
AT diwang knockdownofrfc4inhibitscellproliferationoforalsquamouscellcarcinomainvitroandinvivo
AT zhengliu knockdownofrfc4inhibitscellproliferationoforalsquamouscellcarcinomainvitroandinvivo
AT shuzhenguan knockdownofrfc4inhibitscellproliferationoforalsquamouscellcarcinomainvitroandinvivo
AT ningxiao knockdownofrfc4inhibitscellproliferationoforalsquamouscellcarcinomainvitroandinvivo
AT haotianchen knockdownofrfc4inhibitscellproliferationoforalsquamouscellcarcinomainvitroandinvivo
AT xinzhang knockdownofrfc4inhibitscellproliferationoforalsquamouscellcarcinomainvitroandinvivo
AT lichuanwu knockdownofrfc4inhibitscellproliferationoforalsquamouscellcarcinomainvitroandinvivo
AT guizhenwang knockdownofrfc4inhibitscellproliferationoforalsquamouscellcarcinomainvitroandinvivo
AT haitaodong knockdownofrfc4inhibitscellproliferationoforalsquamouscellcarcinomainvitroandinvivo